Patient-reported outcome measures in severe asthma : an expert consensus
OBJECTIVE: The study aimed to reach a consensus on the most relevant patient-reported outcomes (PROs), the corresponding measures (PROMs), and measurement frequency during severe asthma patient follow-up.
METHODS: Two Delphi rounds were conducted. The questionnaire was developed based on a systematic literature review, a focus group with patients, and a nominal group with experts. It assessed PROs' relevance and the appropriateness (A) and feasibility (F) of PROMs using a Likert scale (1=totally agree; 9=totally disagree). The consensus was established when ≥75% of participants agreed (1-3) or disagreed (7-9).
RESULTS: Sixty-three professionals (25 hospital pharmacists, 14 allergists, 13 pulmonologists, and 11 nurses) and 5 patients answered the Delphi questionnaire. A consensus was reached on all PROs regarding their relevance. Experts agreed on the use of ACT (A:95.24%; F:95.24%), mini AQLQ (A:93.65; F:79.37%), mMRC dyspnea scale (A:85.71%; F:85.71%), TAI (A:92.06%; F:85.71%), MMAS (A:75.40%; F:82%), and the dispensing register (A:96.83%; F:92.06%). Also considered suitable were: SNOT-22 (A:90.48%; F:73.80%), PSQI (A:82.54; F:63.90%), HADS (A:82.54; F:64%), WPAI (A:77.78%; F:49.20%), TSQM-9 (A:79.37; F:70.50%) and knowledge of asthma questionnaire (A:77%; F:68.80%); however, their use in clinical practice was considered unfeasible. Panelists also agreed on the appropriateness of EQ-5D, which was finally included despite being considered unfeasible (A: 84.13%; F:67.20%) in clinical practice. Agreement was reached on using ACT, TAI, mMRC, and a dispensing register every three months; mini-AQLQ and MMAS every six months; and EQ-5D every twelve months.
CONCLUSION: This consensus paves the way toward patient-centered care, promoting the development of strategies supporting routine assessment of PROs in severe asthma management.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
---|---|
Enthalten in: |
The Journal of asthma : official journal of the Association for the Care of Asthma - (2023) vom: 26. Dez., Seite 1-13 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Martínez-Moragón, Eva [VerfasserIn] |
---|
Links: |
---|
Themen: |
Journal Article |
---|
Anmerkungen: |
Date Revised 26.12.2023 published: Print-Electronic Citation Status Publisher |
---|
doi: |
10.1080/02770903.2023.2297372 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366376306 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM366376306 | ||
003 | DE-627 | ||
005 | 20231227141350.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231227s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/02770903.2023.2297372 |2 doi | |
028 | 5 | 2 | |a pubmed24n1239.xml |
035 | |a (DE-627)NLM366376306 | ||
035 | |a (NLM)38146964 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Martínez-Moragón, Eva |e verfasserin |4 aut | |
245 | 1 | 0 | |a Patient-reported outcome measures in severe asthma |b an expert consensus |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 26.12.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status Publisher | ||
520 | |a OBJECTIVE: The study aimed to reach a consensus on the most relevant patient-reported outcomes (PROs), the corresponding measures (PROMs), and measurement frequency during severe asthma patient follow-up | ||
520 | |a METHODS: Two Delphi rounds were conducted. The questionnaire was developed based on a systematic literature review, a focus group with patients, and a nominal group with experts. It assessed PROs' relevance and the appropriateness (A) and feasibility (F) of PROMs using a Likert scale (1=totally agree; 9=totally disagree). The consensus was established when ≥75% of participants agreed (1-3) or disagreed (7-9) | ||
520 | |a RESULTS: Sixty-three professionals (25 hospital pharmacists, 14 allergists, 13 pulmonologists, and 11 nurses) and 5 patients answered the Delphi questionnaire. A consensus was reached on all PROs regarding their relevance. Experts agreed on the use of ACT (A:95.24%; F:95.24%), mini AQLQ (A:93.65; F:79.37%), mMRC dyspnea scale (A:85.71%; F:85.71%), TAI (A:92.06%; F:85.71%), MMAS (A:75.40%; F:82%), and the dispensing register (A:96.83%; F:92.06%). Also considered suitable were: SNOT-22 (A:90.48%; F:73.80%), PSQI (A:82.54; F:63.90%), HADS (A:82.54; F:64%), WPAI (A:77.78%; F:49.20%), TSQM-9 (A:79.37; F:70.50%) and knowledge of asthma questionnaire (A:77%; F:68.80%); however, their use in clinical practice was considered unfeasible. Panelists also agreed on the appropriateness of EQ-5D, which was finally included despite being considered unfeasible (A: 84.13%; F:67.20%) in clinical practice. Agreement was reached on using ACT, TAI, mMRC, and a dispensing register every three months; mini-AQLQ and MMAS every six months; and EQ-5D every twelve months | ||
520 | |a CONCLUSION: This consensus paves the way toward patient-centered care, promoting the development of strategies supporting routine assessment of PROs in severe asthma management | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Severe asthma | |
650 | 4 | |a patient-centered care | |
650 | 4 | |a patient-reported outcome measures | |
650 | 4 | |a patient-reported outcomes | |
700 | 1 | |a Antepara Ercoreca, Ignacio |e verfasserin |4 aut | |
700 | 1 | |a Muñoz García, María |e verfasserin |4 aut | |
700 | 0 | |a PROs-SA group of experts |e verfasserin |4 aut | |
700 | 1 | |a Casas Maldonado, Francisco |e verfasserin |4 aut | |
700 | 1 | |a Calvín Lamas, Marta |e verfasserin |4 aut | |
700 | 1 | |a Chiner Vives, Eusebi |e verfasserin |4 aut | |
700 | 1 | |a Crespo Diz, Carlos |e verfasserin |4 aut | |
700 | 1 | |a Díaz-Pérez, David |e verfasserin |4 aut | |
700 | 1 | |a Eguiluz Gracia, Ibon |e verfasserin |4 aut | |
700 | 1 | |a García Gil, Sara |e verfasserin |4 aut | |
700 | 1 | |a González-Pérez, Ruperto |e verfasserin |4 aut | |
700 | 1 | |a Habernau Mena, Alicia |e verfasserin |4 aut | |
700 | 1 | |a Hermida Valverde, Tamara |e verfasserin |4 aut | |
700 | 1 | |a Jornet Montaña, Sònia |e verfasserin |4 aut | |
700 | 1 | |a López-Carrasco, Valentín |e verfasserin |4 aut | |
700 | 1 | |a Martínez López, Icíar |e verfasserin |4 aut | |
700 | 1 | |a Merino-Bohórquez, Vicente |e verfasserin |4 aut | |
700 | 1 | |a Moreno-Ancillo, Álvaro |e verfasserin |4 aut | |
700 | 1 | |a Mínguez Cabeza, Ana Cristina |e verfasserin |4 aut | |
700 | 1 | |a Monte-Boquet, Emilio |e verfasserin |4 aut | |
700 | 1 | |a Revuelta-Herrero, Jose Luis |e verfasserin |4 aut | |
700 | 1 | |a Sánchez-Cuellar, Silvia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of asthma : official journal of the Association for the Care of Asthma |d 1988 |g (2023) vom: 26. Dez., Seite 1-13 |w (DE-627)NLM01328827X |x 1532-4303 |7 nnns |
773 | 1 | 8 | |g year:2023 |g day:26 |g month:12 |g pages:1-13 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/02770903.2023.2297372 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2023 |b 26 |c 12 |h 1-13 |